Area of research
Psychiatry and Mental health · Biological Psychiatry
Research interest
Research interests include Bipolar Disorder and Treatment, Tryptophan and brain disorders, Psychedelics and Drug Studies, and Treatment of Major Depression.
A Digital Dialectical Behaviour Therapy Intervention for Acute Suicidality in Psychiatric Inpatients: A Feasibility Randomised Controlled Study: Intervention numérique en thérapie comportementale dialectique en cas de suicidabilité aiguë de patients hospitalisés en psychiatrie : Étude de faisabilité contrôlée à répartition aléatoire.
Feasibility and Acceptability of Online Culturally Adapted Cognitive Behavioural Therapy for Depression and Anxiety in Canadians of South Asian Origin: A Randomized Controlled Trial: Faisabilité et acceptabilité de la thérapie cognitivo-comportementale en ligne adaptée à la culture pour traiter la dépression et l'anxiété chez les Canadiens d'origine sud-asiatique : Essai contrôlé à répartition aléatoire.
A longitudinal study of changes in depressive symptoms and risk factors for congestive heart failure.
Associations between structural brain measures and cognitive function in bipolar disorder: a systematic review and meta-analysis.
Innovations in the Treatment of Mood Disorders: Exploring Microbiome, Digital and Culturally Adapted Approaches.
Extending the Impact of Mood Disorder Care Through Treatment Optimization and Accessibility.
Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study.
A randomised controlled feasibility trial comparing culturally adapted psychoeducation and treatment as usual for persons with bipolar disorders in Nigeria.
The effect of the quality of the national health security systems in 12 countries on the prevalence of suicide crisis syndrome during the COVID-19 pandemic.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes.
Mental health and psychosocial interventions in the context of climate change: a scoping review
Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.
Prescribed psychostimulants and other pro-cognitive medications in bipolar disorder: A systematic review and meta-analysis of recurrence of manic symptoms.
Associations between C-reactive protein and individual symptoms of depression in a lower-middle income country.
A History of Suicide Attempt Is Associated with Increased Sympathetic Activation in Bipolar Disorder.
Challenges in defining treatment-resistant mania in adults: A systematic review.
Mood regulation in euthymic patients with a history of antidepressant-induced mania.
Neural effects of psychedelics: Complexity the key word.
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.
Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms.
Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.
Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.
Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depression.
Culturally Adapted Cognitive Behaviour Therapy (CaCBT) to Improve Community Mental Health Services for Canadians of South Asian Origin: A Qualitative Study
Ketamine for bipolar depression: an updated systematic review.
Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.
Cross-national presence and sociodemographic correlates of the suicide crisis syndrome.